Global Biopsy Devices Market Research and Analysis

Global Biopsy Devices Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2015-2021

GLOBAL BIOPSY DEVICES MARKET INSIGHT:

Global biopsy devices market is expected to grow at a CAGR of 8.1% for the forecasted period of 2016-2021. The market study includes segmentation based on the type, therapeutic areas, end users and regional analysis. The market is driven by number of factors, growing cases of cases being the top driver. Recently there has been a rise in the prevalence of cancer cases. Even cases of children below five being diagnosed with several of forms of cancer has increased. This has led to end users which includes hospitals, clinics, diagnostic centres and patients opting for biopsy to get accurate diagnosis of diseases. Other than cancer other biopsy is being used for other therapeutic areas which include kidney biopsy, brain biopsy, nerve biopsy and others.

Biopsy devices by type includes needle based guns, needles, guidance systems and forceps. At present guidance systems have the highest market share followed by needle based devices. Needle based biopsy market is expected to have highest growth rate. There has been constant influx of new products from various companies. One of the major driving factors for new product development is rising demand for minimally invasive procedures.

North America has the highest market share amongst the major regions. North American market is driven by high awareness, availability of reimbursements and a good number of hospitals offering minimally invasive procedures.  Availability of robotic guidance systems is also a major factor. Asia Pacific market is expected to grow with a CAGR of 11.7% for the forecasted period of 2016-2021. APAC market is driven by growing number of diagnosed patients, better healthcare system and improving economies.

The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, patent analysis, pipeline analysis, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

THE REPORT COVERS:

• Comprehensive research methodology of biopsy devices market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global biopsy market
• Insights about market determinants which are stimulating the global biopsy devices market
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players

Market Segments included:

• Biopsy Devices by Type
  • Needle Based Biopsy Guns
  • Biopsy Needles
  • Biopsy
  • Biopsy Guidance Systems
• Biopsy Devices by Therapeutics
  • Bone Marrow Biopsy
  • Breast Biopsy
  • Prostate Biopsy
  • Cancer Liquid Biopsy
  • Kidney Biopsy
  • Liver Biopsy
  • Lung Biopsy
  • Gastrointestinal Biopsy
  • Brain Biopsy
  • Other Biopsy
• Biopsy Devices by End User
  • Hospitals Biopsy
  • Diagnostic Centres Biopsy
  • Clinics Biopsy
  • Others Biopsy

COMPANIES PROFILED IN THE REPORT:

• R. Bard Inc.
• Hologic Inc.
• Stryker Corporation
• Argon Medical Devices
• Becton, Dickinson And Co.
• Devicor Medical Products Inc.
• Encapsule Medical Devices LLC
• Ethicon Endo-Surgery Inc.
• Boston Scientific Corporation
• Cardinal Health Inc.
• Intact Medical Corporation
• Cook Medical Inc.
• Surgical Specialties Corporation
• Carefusion Corporation
• DTR Medical Ltd.
• INRAD Inc.
• Sanarus Technologies LLC
• MDNA Life Sciences Inc.
• MDXHealth Inc.
• Mauna Kea Technologies